Influenza, Human  >>  Rituxan (rituximab)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rituxan (rituximab) / Roche
NCT00466037: The Effect of Rituximab on the Humoral Response to Influenza Vaccine

Terminated
N/A
64
RoW
Influenza vaccine
Tel-Aviv Sourasky Medical Center
Rheumatoid Arthritis
 
02/06
Rituxivac, NCT01707628: Response to Influenza Vaccination in Lymphoma Patients Treated With Rituximab

Completed
N/A
98
Europe
influenza vaccination with influenza vaccine, Influvac, Vaxigrip
St. Antonius Hospital
Non-Hodgkin Lymphoma (NHL)
06/13
06/13

Download Options